Skip to main content
Log in

Is Partial or Total Thyroidectomy Associated with Risk of Long-Term Osteoporosis: A Nationwide Population-Based Study

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Whether thyroidectomy contributes to osteoporosis (OP) and osteoporotic fracture (OF) is a subject of debate. This study aimed to determine the effect of thyroidectomy on the risk of OP and OF.

Methods

This retrospective cohort study is based on patient data between January 2000 to December 2005 from the National Health Insurance Research Database. Patients who underwent thyroidectomy were enrolled in the thyroidectomy cohort, and the control cohort was selected by propensity score matching at a ratio of 1:4. Incident OP and OF cases were identified until the end of 2013. The thyroidectomy cohort to control cohort adjusted hazard ratio (aHR) for OP/OF was assessed through multivariable Cox proportional hazard regression analysis.

Results

Totals of 1426 and 5704 patients were included in the thyroidectomy and control cohorts, respectively. The incidence density of OP was higher in the thyroidectomy cohort (7.91/1000 person-years) than in the control cohort (5.98/1000 person-years), with an aHR of 1.43 (95% CI 1.16–1.77, p < 0.05). Younger patients, women, and patients with comorbidities were at a higher risk. The risks of postoperative OP/OF were significantly increased in patients who received thyroxine treatment for more than 1 year, both in the partial thyroidectomy group and in the total and subtotal thyroidectomy group (aHR: 2.47, 95% CI: 1.42–2.31 vs. aHR: 1.84, 95% CI: 1.22–2.76).

Conclusion

Thyroidectomy significantly increased the long-term risk of OP. Younger patients, women, patients with comorbidities, and patients receiving chronic thyroxin treatment should be monitored for changes in postoperative bone density.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

BNHI:

Bureau of National Health Insurance

CI:

Confidence interval

HR:

Hazard ratio

NHI:

National Health Insurance

NHIRD:

National Health Insurance Research Database

NHRI:

National Health Research Institute

OF:

Osteoporotic fracture

OP:

Osteoporosis

TSH:

Thyroid-stimulating hormone

References

  1. Tunca F, Senyurek YG, Terzioglu T et al (2009) Impact of total versus subtotal thyroidectomy on calcium metabolism and bone mineral density in premenopausal women. J Laryngol Otol 123:434–438

    Article  PubMed  CAS  Google Scholar 

  2. Schneider P, Berger P, Kruse K et al (1991) Effect of calcitonin deficiency on bone density and bone turnover in totally thyroidectomized patients. J Endocrinol Invest 14:935–942

    Article  PubMed  CAS  Google Scholar 

  3. Nguyen TT, Heath H 3rd, Bryant SC et al (1997) Fractures after thyroidectomy in men: a population-based cohort study. J Bone Miner Res 12:1092–1099

    Article  PubMed  CAS  Google Scholar 

  4. Melton LJ 3rd, Ardila E, Crowson CS et al (2000) Fractures following thyroidectomy in women: a population-based cohort study. Bone 27:695–700

    Article  PubMed  Google Scholar 

  5. Mirzaei S, Krotla G, Knoll P et al (1999) Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy. Acta Med Austriaca 26:29–31

    PubMed  CAS  Google Scholar 

  6. Sugitani I, Fujimoto Y (2011) Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study. Surgery 150:1250–1257

    Article  PubMed  Google Scholar 

  7. Moon JH, Jung KY, Kim KM et al (2016) The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma. Bone 83:104–110

    Article  PubMed  CAS  Google Scholar 

  8. Papaleontiou M, Hawley ST, Haymart MR (2016) Effect of thyrotropin suppression therapy on bone in thyroid cancer patients. Oncologist 21:165–171

    Article  PubMed  CAS  Google Scholar 

  9. Wang LY, Smith AW, Palmer FL et al (2015) Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma. Thyroid 25:300–307

    Article  PubMed  CAS  Google Scholar 

  10. Tournis S, Antoniou JD, Liakou CG et al (2015) Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression. Clin Endocrinol 82:197–204

    Article  Google Scholar 

  11. Marcocci C, Golia F, Bruno-Bossio G et al (1994) Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 78:818–823

    PubMed  CAS  Google Scholar 

  12. Kim CW, Hong S, Oh SH et al (2015) Change of bone mineral density and biochemical markers of bone turnover in patients on suppressive levothyroxine therapy for differentiated thyroid carcinoma. J Bone Metab 22:135–141

    Article  PubMed  PubMed Central  Google Scholar 

  13. Vera L, Gay S, Campomenosi C et al (2016) Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy. Endokrynol Pol 67:350–358

    PubMed  CAS  Google Scholar 

  14. Sung PS, Yeh CC, Wang LC et al (2017) Increased risk of dementia in patients with non-apnea sleep disorder. Curr Alzheimer Res 14:309–316

    PubMed  CAS  Google Scholar 

  15. Tsai MC, Tsai KJ, Wang HK et al (2014) Mood disorders after traumatic brain injury in adolescents and young adults: a nationwide population-based cohort study. J Pediatr 164(136–141):e131

    Google Scholar 

  16. Huang CY, Li YC, Wang HK et al (2015) Stroke suggests increased risk of dementia. Curr Alzheimer Res 12:287–295

    Article  PubMed  CAS  Google Scholar 

  17. Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133

    Article  PubMed  PubMed Central  Google Scholar 

  18. Reverter JL, Holgado S, Alonso N et al (2005) Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Endocr Relat Cancer 12:973–981

    Article  PubMed  CAS  Google Scholar 

  19. Cavalli L, Guazzini A, Cianferotti L et al (2016) Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign BMC. Musculoskelet Disord 17:396

    Article  Google Scholar 

  20. Nguyen ND, Frost SA, Center JR et al (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431–1444

    Article  PubMed  CAS  Google Scholar 

  21. Hernlund E, Svedbom A, Ivergard M, et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136

  22. Khadilkar AV, Mandlik RM (2015) Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Women’s Health 7:841–850

    Article  CAS  Google Scholar 

  23. Diamond T, Nery L, Hales I (1991) A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72:1184–1188

    Article  PubMed  CAS  Google Scholar 

  24. Garton M, Reid I, Loveridge N et al (1994) Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy. Clin Endocrinol 41:747–755

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by grants from Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004) and Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kuen-Jer Tsai.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hung, CL., Yeh, CC., Sung, PS. et al. Is Partial or Total Thyroidectomy Associated with Risk of Long-Term Osteoporosis: A Nationwide Population-Based Study. World J Surg 42, 2864–2871 (2018). https://doi.org/10.1007/s00268-018-4573-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-018-4573-2

Navigation